Hydrogen Research Study
← Back to Research Library
Review or synthesisNarrative reviewOther or not reported

Advances in Hydrodechlorination Technologies for Diclofenac Removal from Aqueous Systems.

Cristian Castillo, Jorge A Mora, Maria H Brijaldo · Molecules (Basel, Switzerland) · 2025

Research-use notice

Independent study record

Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.

H2HUBB Research Library branded molecular hydrogen research image
Primary topic Reviews and Meta-Analyses
Evidence type Review or synthesis
Publication type Narrative review
Hydrogen method Other or not reported

H2HUBB TAKEAWAY

This narrative review examined the available molecular-hydrogen literature. Various strategies for the HDC of DFC are discussed, including conventional approaches that rely on molecular hydrogen as the electron donor, as well as emerging alternatives based on biocatalytic and electrocatalytic processes. Biocatalytic systems benefit from environmental friendliness and unique microbial–catalyst interactions; however, their catalytic efficiency and selectivity can be limited by the intrinsic properties of bio-Pd NPs and potential mass transfer limitations in complex matrices. The reviewed evidence adds support for molecular hydrogen's therapeutic potential across the conditions, mechanisms, or outcomes examined.

What the Findings Mean

H2HUBB reviewed this publication as a synthesis of molecular-hydrogen research and summarizes the outcomes emphasized by the authors. Various strategies for the HDC of DFC are discussed, including conventional approaches that rely on molecular hydrogen as the electron donor, as well as emerging alternatives based on biocatalytic and electrocatalytic processes.

What the Researchers Studied

The authors reviewed advances in Hydrodechlorination Technologies for Diclofenac Removal from Aqueous Systems.

What Effects Did Molecular Hydrogen Have?

Various strategies for the HDC of DFC are discussed, including conventional approaches that rely on molecular hydrogen as the electron donor, as well as emerging alternatives based on biocatalytic and electrocatalytic processes. The authors concluded that biocatalytic systems benefit from environmental friendliness and unique microbial–catalyst interactions; however, their catalytic efficiency and selectivity can be limited by the intrinsic properties of bio-Pd NPs and potential mass transfer limitations in complex matrices.

Why These Findings Matter

The reviewed evidence adds support for molecular hydrogen's therapeutic potential across the conditions, mechanisms, or outcomes examined.

How Strong Is This Evidence?

This is review or synthesis evidence (narrative review).

Technical Study Details

H2HUBB classifies this publication as narrative review with review or synthesis evidence. The study used a narrative review.

Limitations and Safety

Reported limitations: Biocatalytic systems benefit from environmental friendliness and unique microbial–catalyst interactions; however, their catalytic efficiency and selectivity can be limited by the intrinsic properties of bio-Pd NPs and potential mass transfer limitations in complex matrices.

Original Study and H2HUBB Research Context

H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.